IMU Biosciences announced that it has received £11.5 million in a round of funding led by new investor Molten Ventures Plc on January 24, 2024. The transaction included participation from new investor Life Extension Ventures and other individuals. Oliver Nussbaumer and inga Deakin from Molten Ventures Plc will join board of directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
247.5 GBX | +4.21% | +10.49% | -10.84% |
Apr. 25 | The specter of stagflation rears its ugly head again | |
Apr. 23 | Molten Ventures up after slow 2024 | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.84% | 579M | |
+31.41% | 12.02B | |
+14.40% | 3.06B | |
+2.96% | 1.42B | |
-8.46% | 1.22B | |
+1.15% | 616M | |
+35.79% | 577M | |
-4.17% | 492M | |
+33.85% | 488M | |
+3.90% | 304M |
- Stock Market
- Equities
- GROW Stock
- News Molten Ventures Plc
- IMU Biosciences announced that it has received £11.5 million in funding from Life Extension Ventures, Molten Ventures Plc and other investors